1.
Dig Dis Sci
; 48(1): 169-73, 2003 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12645805
RESUMO
Although interferon has not been classified in the pathogenesis of sarcoidosis, it may rarely lead to this disease during treatment of chronic hepatitis C. The case of a 36-year-old woman with chronic hepatitis C who developed sarcoidosis within 10 weeks of treatment with recombinant interferon-alpha2a and ribavirin is described and all seven similar cases published in English from 1989 to 2001 are discussed.